Author:
Riestra Sabino,Taxonera Carlos,Zabana Yamile,Carpio Daniel,Beltrán Belén,Mañosa Míriam,Gutiérrez Ana,Barreiro-de Acosta Manuel
Reference101 articles.
1. Tuberculosis associated with infliximab, a tumor necrosis factor α-neutralizing agent;Keane;N Engl J Med.,2001
2. Consensus guideline on tuberculosis and treatment of inflammatory bowel disease with infliximab;Obrador;Gas-troenterol Hepatol.,2003
3. en representación de GETECCU: Recomendaciones del Grupo Español de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa (GETECCU) sobre el cribado y tratamiento de la tuberculosis latente en pacientes con enfermedad inflamatoria intestinal;Riestra;Enferm Inflam Intest Dia.,2015
4. ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an infectious diseases perspective (Soluble immune effector molecules [I]: anti-tumor necrosis factor-alpha agents);Baddley;Clin Microbiol Infect.,2018